What are the benefits of CBD Microdosing? Some research supported CBD Microdosing benefits include pain relief, stress reduction, better sleep, and improved mood. Learn about CBD Microdosing.
CBD Microdosing Benefits
A previous article defined what is CBD Microdosing. This article explains some of the benefits.
CBD Microdosing for Pain Relief
One of the most common reasons people use CBD is for pain relief. Several studies have found that CBD can reduce pain and inflammation, including chronic pain conditions such as arthritis and neuropathic pain.
A randomized, double-blind, placebo-controlled study found that CBD significantly reduced pain and improved sleep in people with chronic pain conditions [1]. Another study found that CBD was effective in reducing pain and improving quality of life in people with multiple sclerosis [2].
CBD Microdosing for Anxiety and Stress Reduction
CBD has also been shown to have anxiolytic and stress-reducing effects. A study published in the Journal of Clinical Psychology found that CBD significantly reduced anxiety in people with social anxiety disorder [3]. Another study found that CBD had a calming effect on the nervous system, reducing stress and anxiety in people with generalized anxiety disorder.
CBD Microdosing for Sleep
CBD has been found to improve sleep quality and duration, particularly in people with sleep disorders such as insomnia. A study published in the Permanente Journal found that CBD improved sleep and reduced anxiety in a group of people with anxiety and sleep disorders. Another study found that CBD improved the quality of sleep and reduced daytime sleepiness in people with Parkinson’s disease.
Various prepared CBD and CBN tinctures exist to help improve the quality of sleep naturally.
CBD Microdosing for Mood
CBD may also have mood-boosting effects. A study published in the Journal of Psychopharmacology found that CBD reduced symptoms of depression in a group of people with social anxiety disorder. Another study found that CBD had an antidepressant effect in animal models.
Product Selection
When microdosing CBD, it’s important to choose the right product. Tinctures, softgels, and edibles are all popular choices for microdosing. Look for a product that is specifically formulated for microdosing and contains a consistent amount of CBD per serving. Additionally, it’s important to choose a product that has been third-party tested for quality and purity.
Dosage
The optimal dosage for microdosing CBD may vary from person to person. It’s recommended to start with a low dose, such as 5-10mg, and gradually increase the dosage until you achieve the desired effects. It’s also important to be consistent with your dosing and take the same amount of CBD at the same time each day.
Risks and Side Effects
CBD is generally considered safe and well-tolerated, with few side effects reported. However, some people may experience mild side effects such as fatigue, nausea, and dry mouth. CBD may also interact with certain medications, so it’s important to talk to a healthcare professional before starting CBD microdosing, particularly if you are taking medications or have a medical condition.
Summary of CBD Microdosing: What Are The Benefits?
CBD microdosing has shown promise for a variety of health conditions, including pain, anxiety, sleep, and mood disorders. While more research is needed, the available evidence suggests that CBD may be a safe and effective way to promote better overall health and wellbeing.
As with any supplement, it’s important to talk to a healthcare professional before starting CBD microdosing, particularly if you are taking medications or have a medical condition.
Was the article CBD Microdosing: What Are The Benefits useful? Then you may enjoy:
References:
- Malfait AM, Gallily R, Sumariwalla PF, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 2000;97(17):9561-9566.
- Zajicek JP, Hobart JC, Slade A, et al. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012;83(11):1125-1132.
- Crippa JA, Derenusson